医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
2-(2-(3-(2-(7-氯-2-喹啉基)-乙烯基苯基)-3-羟基丙基)苯基)-2-丙醇 | (S)-1-{3-[2-(7-chloroquinolin-2-yl)ethylene]-phenyl}-3-[2-(1-hydroxy-1-methylethyl)phenyl]-propan-1-ol | 142569-70-8 | C29H28ClNO2 |
|
2-(2-(1H-吲哚-3-基)乙基氨基)乙醇 | (2-Hydroxy-ethyl)-<2-(3-indolyl)-ethyl>-amin | 37465-61-5 | C12H16N2O |
|
2-(2,6-二氧代-哌啶-3-基)-5-氟-异吲哚-1,3-二酮 | 2-(2,6-dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione | 835616-61-0 | C13H9FN2O4 |
|
2-(2,6-二氧代-哌啶-3-基)-4-羟基-异吲哚-1,3-二酮 | 2-(2,6-dioxopiperidin-3-yl)-4-hydroxyisoindoline-1,3-dione | 5054-59-1 | C13H10N2O5 |
|
2-(2,6-二氧代-哌啶-3-基)-4-氟基-异吲哚-1,3-二酮 | 2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione | 835616-60-9 | C13H9FN2O4 |
|
2-(2,4-二硝基苯甲基)吡啶 | 2-(2,4-dinitrobenzyl)pyridine | 1151-97-9 | C12H9N3O4 |
|
2-(2,4-二硝基-苯氧基)-异吲哚-1,3-二酮 | 2-(2,4-dinitrophenoxy)-1H-isoindole-1,3(2H)-dione | 60506-35-6 | C14H7N3O7 |
|
2-(2,4-二氯苯氧基)吡啶 | 2-(2,4-dichlorophenoxy)pyridine | 4783-79-3 | C11H7Cl2NO |
|
2-(2,4-二氯苯基)-4-(二氟甲基)-2,4-二氢-5-甲基-3H-1,2,4-三唑-3-酮 | 1-(2,4-dichlorophenyl)-3-methyl-4-difluoromethyl-1,2,4-triazol-5-one | 111992-16-6 | C10H7Cl2F2N3O |
|
2-(2,4-二氯苄基)苯并咪唑 | 2-(2,4-dichlorobenzyl)benzimidazole | 154660-96-5 | C14H10Cl2N2 |
|
2-(2,4-二氟苯氧基)-3-硝基吡啶 | 2-(2,4-difluorophenoxy)-3-nitropyridine | 175135-62-3 | C11H6F2N2O3 |
|
2-(2,4-二氟苯基)吡啶 | 2-(2,4-difluorophenyl)pyridine | 391604-55-0 | C11H7F2N |
|
2-(2,4-二氟苯基)-6-氯吡啶-3-羧酸乙酯 | ethyl 6-chloro-2-(2,4-difluorophenyl)nicotinate | 745833-19-6 | C14H10ClF2NO2 |
|
2-(2,3-二羟基苯基)-4H-苯并吡喃-4-酮 | 2',3'-dihydroxyflavone | 2554-85-0 | C15H10O4 |
|
2-(2,3-二甲苯氧基)-3-硝基吡啶 | 2-(2,3-Dimethylphenoxy)-3-nitropyridine | 76893-55-5 | C13H12N2O3 |
|
2-(2,3-二氢噻吩并[3,4-b][1,4]二噁英-5-基)-4,4,5,5-四甲基-1,3,2-二噁硼烷 | 2-(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 250726-93-3 | C12H17BO4S |
|
2-(2,2,2-三氟乙氧基)吡啶-3-甲腈 | 2-(2,2,2-Trifluoroethoxy)pyridine-3-carbonitrile | 175277-89-1 | C8H5F3N2O |
|
2-(2'-甲基苯基)哌啶 | 2-(2'-methylphenyl)piperidine | 118576-99-1 | C12H17N |
|
2-(2',4'-二甲苯氨基)-3-甲基-6-二乙氨基荧烷(B15) | Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 6'-(diethylamino)-2'-[(2,4-dimethylphenyl)amino]-3'-methyl- | 36431-22-8 | C33H32N2O3 |
|
2-(1H-咪唑-1-基)乙胺 | N-[2-(aminoethyl)]imidazole | 5739-10-6 | C5H9N3 |
|
2-(1H-吲唑-6-基硫代)-N-甲基苯甲酰胺 | 2-((1H-indazol-6-yl)thio)-N-methylbenzamide | 944835-85-2 | C15H13N3OS |
|
2-(1H-吲哚-4-基)乙胺 | 2-(1H-indol-4-yl)ethanamine | 16176-73-1 | C10H12N2 |
|
2-(1H-吲哚-3-基)-2-甲基-1-丙胺 | 2-(1H-indol-3-yl)-2-methylpropane-1-amine | 15467-31-9 | C12H16N2 |
|
2-(1H-吲哚)-4-乙酸 | indole-4-acetic acid | 16176-74-2 | C10H9NO2 |
|
2-(1H-吡唑-4-基)喹噁啉 | 2-(1H-pyrazol-4-yl)quinoxaline | 439106-90-8 | C11H8N4 |
|
2-(1H-吡唑-4-基)喹啉 | 2-(1H-pyrazol-4-yl)quinoline | 439106-87-3 | C12H9N3 |
|
2-(1H-吡唑-4-基)吡啶 | 2-(1H-pyrazol-4-yl)pyridine | 439106-75-9 | C8H7N3 |
|
2-(1H-吡唑-3-基)-乙醇 | 2-(1H-pyrazol-3-yl)ethanol | 32385-74-3 | C5H8N2O |
|
2-(1H-吡咯并[2,3-b]吡啶-3-基)乙胺 | 2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-ethylamine | 4649-12-1 | C9H11N3 |
|
2-(1H-吡咯[2,3-B]并吡啶)-3-乙酸 | 2-cyclopropylacetaldehyde | 56105-19-2 | C5H8O |
|
2-(1H-吡咯-2-基)吡啶 | 2-(1H-pyrrol-2-yl)pyridine | 17285-54-0 | C9H8N2 |
|
2-(1H-2-咪唑)-嘧啶 | 2-(1H-imidazol-2-yl)pyrimidine | 627910-87-6 | C7H6N4 |
|
2-(1H-1,2,4-三唑-5-基)吡嗪 | 3-pyrazinyl-1,2,4-triazole | 130612-31-6 | C6H5N5 |
|
2-(1H-1,2,4-三唑-3-基)吡啶 | 2-(1H-1,2,4-triazol-3-yl)pyridine | 23195-62-2 | C7H6N4 |
|
2-(1-金刚烷基)乙酸甲酯 | methyl (1-adamantyl)acetate | 27174-71-6 | C13H20O2 |
|
2-(1-金刚烷基)-4-溴苯酚 | 2-(1-adamantyl)-4-bromophenol | 104224-68-2 | C16H19BrO |
|
2-(1-金刚烷基)-4-溴苯甲醚 | 2-(1-adamantyl)-4-bromoanisole | 104224-63-7 | C17H21BrO |
|
2-(1-苯基乙酮-2-基)异吲哚啉-1,3-二酮 | N-benzoylmethylphthalimide | 1032-67-3 | C16H11NO3 |
|
2-(1-苯基-1H-5-吡唑基)嘧啶 | 2-(1-phenyl-1H-pyrazol-5-yl)pyrimidine | 1269291-79-3 | C13H10N4 |
|
2-(1-羟乙基)吡啶 | 1-(2-Pyridyl)ethanol | 18728-61-5 | C7H9NO |
|
2-(1-甲苯基-1H-5-吡唑基)嘧啶 | 2-(1-(p-Tolyl)-1H-pyrazol-5-yl)pyrimidine | 1269292-37-6 | C14H12N4 |
|
2-(1-甲基乙基)-4-噻唑羧醛 | 2-isopropyl-thiazole-4-carbaldehyde | 133047-46-8 | C7H9NOS |
|
2-(1-甲基乙基)-4-嘧啶胺 | 4-amino-2-i-propylpyrimidine | 114362-19-5 | C7H11N3 |
|
2-(1-甲基-2-亚吡咯烷基)乙酸甲酯 | Acetic acid, (1-methyl-2-pyrrolidinylidene)-, methyl ester | 78167-68-7 | C8H13NO2 |
|
2-(1-甲基-1H-吡唑-4-基)-乙醇 | 2-(1-methyl-1H-pyrazol-4-yl)ethanol | 176661-75-9 | C6H10N2O |
|
2-(1-氯乙基)吡啶 | 2-(1-chloroethyl)pyridine | 10445-92-8 | C7H8ClN |
|
2-(1-氨基-1-甲基乙基)-N-[(4-氟苯基)甲基]-5-羟基-1-甲基-6-氧代-1,6-二氢嘧啶-4-甲酰胺 | 2-(2-aminopropan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide | 518048-03-8 | C16H19FN4O3 |
|
2-(1-吡咯烷基)嘧啶-5-硼酸频哪酯 | 2-(pyrrolidin-1-yl)-5-(4.,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)pyrimidine | 1015242-07-5 | C14H22BN3O2 |
|
2-(1-吡咯烷)烟酸 | 2-pyrrolidin-1-yl-nicotinic acid | 690632-36-1 | C10H12N2O2 |
|
2-(1-乙基戊基)-1,3-二恶烷-5-醇 | 2-(1-Ethylpentyl)-1,3-dioxan-5-ol | 4969-00-0 | C11H22O3 |
|